SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
1-Year Return
17.43%
This Quarter Return
+33.62%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.69B
AUM Growth
-$90.7M
(-5.1%)
Cap. Flow
-$378M
Cap. Flow
% of AUM
-22.32%
Top 10 Holdings %
Top 10 Hldgs %
52.96%
Holding
89
New
27
Increased
18
Reduced
14
Closed
20
Top Buys
| 1 |
Novo Nordisk
NVO
|
$78.6M |
| 2 |
Incyte
INCY
|
$58.7M |
| 3 |
argenx
ARGX
|
$41.2M |
| 4 |
Idexx Laboratories
IDXX
|
$40.6M |
| 5 |
Insulet
PODD
|
$34.5M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$437M |
| 2 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$150M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$45.9M |
| 4 |
Eli Lilly
LLY
|
$37.6M |
| 5 |
Cytokinetics
CYTK
|
$34.6M |
Sector Composition
| 1 | Healthcare | 99.18% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Immatics
IMTX
$660M
| $22.7M | 1.27% |
2,163,646
-805,393
| -27% | -$8.46M |
|
|
SILK
27
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $21.8M | 1.21% |
+1,189,024
| New | +$21.8M |
|
28
Cogent Biosciences
COGT
$1.8B
| $16.1M | 0.9% |
+2,400,771
| New | +$16.1M |
|
29
Exact Sciences
EXAS
$9.91B
| $15.8M | 0.88% |
+229,481
| New | +$15.8M |
|
30
Alnylam Pharmaceuticals
ALNY
$59.7B
| $15.4M | 0.86% |
+103,036
| New | +$15.4M |
|
31
Immunome
IMNM
$838M
| $14.7M | 0.82% |
+594,396
| New | +$14.7M |
|
32
Pharvaris
PHVS
$1.43B
| $13.5M | 0.75% |
584,672
+74,231
| +15% | +$1.72M |
|
|
MRNS
33
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $12.7M | 0.71% |
1,401,053
-371,646
| -21% | -$3.36M |
|
34
Savara
SVRA
$598M
| $11.7M | 0.65% |
2,347,261
-35,574
| -1% | -$177K |
|
|
SWAV
35
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $11.4M | 0.63% |
+35,000
| New | +$11.4M |
|
36
Kura Oncology
KURA
$704M
| $10.7M | 0.6% |
501,940
-1,165,381
| -70% | -$24.9M |
|
37
Roivant Sciences
ROIV
$8.73B
| $10.6M | 0.59% |
+1,001,704
| New | +$10.6M |
|
|
AXNX
38
DELISTED
Axonics, Inc. Common Stock
AXNX
| $10.3M | 0.57% |
+149,385
| New | +$10.3M |
|
39
PepGen
PEPG
$41.7M
| $7.4M | 0.41% |
503,624
+480,586
| +2,086% | +$7.06M |
|
40
Cabaletta Bio
CABA
$139M
| $7.33M | 0.41% |
429,746
+351
| +0.1% | +$5.99K |
|
41
Establishment Labs
ESTA
$1.12B
| $7.19M | 0.4% |
141,162
+138,110
| +4,525% | +$7.03M |
|
42
Achieve Life Sciences
ACHV
$143M
| $6.9M | 0.38% |
+1,518,230
| New | +$6.9M |
|
43
Soleno Therapeutics
SLNO
$3.63B
| $6.45M | 0.36% |
150,775
+149,575
| +12,465% | +$6.4M |
|
44
4D Molecular Therapeutics
FDMT
$289M
| $6.31M | 0.35% |
+198,186
| New | +$6.31M |
|
45
NextCure
NXTC
$13M
| $5.96M | 0.33% |
222,655
| – | – |
|
46
Avantor
AVTR
$8.89B
| $5.94M | 0.33% |
+232,446
| New | +$5.94M |
|
47
Madrigal Pharmaceuticals
MDGL
$9.56B
| $5.08M | 0.28% |
+19,029
| New | +$5.08M |
|
48
Bolt Biotherapeutics
BOLT
$9.41M
| $3.86M | 0.21% |
137,722
| – | – |
|
|
FUSN
49
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $3.35M | 0.19% |
157,172
+31,873
| +25% | +$680K |
|
50
Masimo
MASI
$7.72B
| $2.94M | 0.16% |
20,000
+7,200
| +56% | +$1.06M |
|